Showing results (861-870 of 2,504) with videos related to
Sort By:
Pageof 251
Journal of Diabetes Investigation|May 21, 2014
Pioglitazone and metformin are equally effective in reduction of chemerin in patients with type 2 diabetesAlireza Esteghamati, Mehrnaz Ghasemiesfe, Mostafa Mousavizadeh, et al.Journal of Diabetes Investigation|July 24, 2020
Microencapsulation of cells and molecular therapy of type 1 diabetes mellitus: The actual state and future perspectives between promise and progressGiuseppe Basta, Pia Montanucci, Riccardo CalafioreJournal of Diabetes Investigation|March 25, 2015
Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetesMasaki Kondo, Hideki Kamiya, Tatsuhito Himeno, et al.Journal of Diabetes Investigation|March 25, 2015
Liver steatosis is associated with insulin resistance in skeletal muscle rather than in the liver in Japanese patients with non-alcoholic fatty liver diseaseKen-Ichiro Kato, Yumie Takeshita, Hirofumi Misu, et al.Journal of Diabetes Investigation|March 25, 2015
Response to the dipeptidyl peptidase-4 inhibitors in Japanese patients with type 2 diabetes might be associated with a diplotype of two single nucleotide polymorphisms on the interleukin-6 promoter region under a certain level of physical activityMizue Matsui, Yoshihiko Takahashi, Noriko Takebe, et al.Journal of Diabetes Investigation|March 25, 2015
Vildagliptin vs liraglutide as a second-line therapy switched from sitagliptin-based regimens in patients with type 2 diabetes: A randomized, parallel-group studyYumie Takeshita, Toshinari Takamura, Yuki Kita, et al.Journal of Diabetes Investigation|March 25, 2015
Efficacy and safety of lixisenatide in Japanese patients with type 2 diabetes mellitus inadequately controlled by sulfonylurea with or without metformin: Subanalysis of GetGoal-SYukiko Onishi, Elisabeth Niemoeller, Yukio Ikeda, et al.Journal of Diabetes Investigation|March 25, 2015
Efficacy and safety of canagliflozin alone or as add-on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52-week open-label studyNobuya Inagaki, Kazuoki Kondo, Toru Yoshinari, et al.Journal of Diabetes Investigation|April 24, 2023
Linagliptin ameliorated cardiac fibrosis and restored cardiomyocyte structure in diabetic mice associated with the suppression of necroptosisJuthi Adhikari, Taro Hirai, Emi Kawakita, et al.Journal of Diabetes Investigation|July 11, 2020
Loss of lower extremity muscle strength based on diabetic polyneuropathy in older patients with type 2 diabetes: Multicenter Survey of the Isometric Lower Extremity Strength in Type 2 Diabetes: Phase 2 studyTakuo Nomura, Toshihiro Kawae, Hiroaki Kataoka, et al.Pageof 251